丰原药业：控股股东及其一致行动人协议转让公司部分股份过户完成

Core Viewpoint - The company announced a share transfer involving 23.7 million shares, representing 5.1% of its total equity, at a price of 6.72 RMB per share, totaling 159 million RMB [1] Group 1: Share Transfer Details - The controlling shareholder, Fengyuan Group, along with its concerted party, Ma'anshan Fengyuan, transferred 23.7 million shares to Hainan Guihe Dayi Investment Partnership [1] - After the transfer, Fengyuan Group and its concerted parties' holdings decreased from 133 million shares to 109 million shares, now representing 23.51% of the total equity [1] Group 2: New Shareholder Information - Hainan Guihe Dayi has become the third-largest shareholder of the company [1] - The new shareholder has committed to not reducing their stake within the next eighteen months [1]